Kirsten Bibbins-Domingo, PhD, MD, MAS

Professor

Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Chair in Medicine, Professor and Chair of the Department of Epidemiology and Biostatistics, and Professor of Medicine. She is the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. Dr. Bibbins-Domingo co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on discovery, implementation, policy, advocacy, and community engagement for communities at risk for poor health and inadequate healthcare. She is one of the PIs of the UCSF Clinical and Translational Science Institute.

Dr. Bibbins-Domingo is a general internist, cardiovascular disease epidemiologist, and a national leader in prevention. She has particular interest in patterns of poor health at younger ages and in racial and ethnic minority populations. Dr. Bibbins-Domingo is an NIH-funded researcher who uses observational studies, pragmatic trials, and simulation modeling to examine effective clinical, public health, and policy interventions aimed at prevention. She leads the UCSF Cardiovascular Disease Policy Model group that conducts simulation modeling, disease projections, and cost-effectiveness analyses related to cardiovascular disease in the US and in other national contexts.

Dr. Bibbins-Domingo was a member of the US Preventive Services Task Force from 2010-2017 and led the Task Force as the vice-chair and chair from 2014-2017. She is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.
Education
MAS, 2004 - Masters in Clinical Research, UCSF, Epidemiology and Biostatistics
Residency, 2001 - Internal Medicine, UCSF, Medicine
MD, 1999 - Medicine, UCSF, Medicine
PhD, 1994 - Biochemistry, UCSF, Biochemistry
AB, 1987 - Molecular Biology & Woodrow Wilson School of Public and International Affairs, Princeton University
Honors and Awards
  • Distinguished Professor of Women and Medicine, Society of General Internal Medicine, 2019
  • Harold S. Luft Award for Mentoring in Health Services and Health Policy Research, UCSF Philip R. Lee Institute for Health Policy Studies, 2019
  • Ancel Keys Memorial Lecture, American Heart Association, 2017
  • Elected to membership, Association of American Physicians, 2017
  • Chancellor's Award for Public Service, UCSF, 2017
  • Elected to membership, National Academy of Medicine, 2015
  • Mid-career Research Mentor Award, Society of General Internal Medicine, 2014
  • Lee Goldman, MD Endowed Chair in Medicine, UCSF, 2012
  • Elected to membership, American Society for Clinical Investigation, 2010
Websites
Publications
  1. Food Insecurity Is Associated With Poorer Mental Health and Sleep Outcomes in Young Adults.
  2. Food Insecurity and Chronic Disease in US Young Adults: Findings from the National Longitudinal Study of Adolescent to Adult Health.
  3. Integrating Social Care Into the Delivery of Health Care.
  4. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
  5. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.
  6. Association Between Food Insecurity and Migraine Among US Young Adults.
  7. The Cardiovascular Health Burdens of Solitary Confinement.
  8. Predictors of muscularity-oriented disordered eating behaviors in U.S. young adults: A prospective cohort study.
  9. Racial/ethnic-specific differences in the effects of inhaled corticosteroid use on bronchodilator response in patients with asthma.
  10. Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals.
  11. Using mobile technology to engage sexual and gender minorities in clinical research.
  12. The Future of Observational Epidemiology: Improving Data and Design to Align With Population Health.
  13. The Promise of Precision Population Health: Reducing Health Disparities Through a Community Partnership Framework.
  14. Genetic risk, body mass index, and weight control behaviors: Unlocking the triad.
  15. Power of the Positive: Childhood Assets and Future Cardiometabolic Health.
  16. Pre-pregnancy kidney function and subsequent adverse pregnancy outcomes.
  17. Acculturation is Associated with Asthma Burden and Pulmonary Function in Latino Youth: The GALA II Study.
  18. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
  19. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
  20. Use of a pooled cohort to impute cardiovascular disease risk factors across the adult life course.
  21. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
  22. Boys, Bulk, and Body Ideals: Sex Differences in Weight-Gain Attempts Among Adolescents in the United States.
  23. Genetic Determinants of Telomere Length in African American Youth.
  24. Differential Risk Factors for Unhealthy Weight Control Behaviors by Sex and Weight Status Among U.S. Adolescents.
  25. The Association of Serum Carotenoids, Tocopherols, and Ascorbic Acid With Rapid Kidney Function Decline: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
  26. The new era of precision population health: insights for the All of Us Research Program and beyond.
  27. Disordered eating behaviors and cardiometabolic risk among young adults with overweight or obesity.
  28. Safety-net institutions in the US grapple with new cholesterol treatment guidelines: a qualitative analysis from the PHoENIX Network.
  29. Adapting and Evaluating a Health System Intervention From Kaiser Permanente to Improve Hypertension Management and Control in a Large Network of Safety-Net Clinics.
  30. Can Survival Bias Explain the Age Attenuation of Racial Inequalities in Stroke Incidence?: A Simulation Study.
  31. Prevalence and Correlates of Disordered Eating Behaviors Among Young Adults with Overweight or Obesity.
  32. Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.
  33. Using Social Media to Target Cancer Prevention in Young Adults: Viewpoint.
  34. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
  35. Why "More Research Is Needed," Despite Overall Certainty: Women and Colorectal Cancer Screening.
  36. Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors.
  37. Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study.
  38. Advancing the Methods of the U.S. Preventive Services Task Force.
  39. Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.
  40. Update on the Methods of the U.S. Preventive Services Task Force: Linking Intermediate Outcomes and Health Outcomes in Prevention.
  41. Whom to Treat for High Blood Pressure-Time for a Precision Approach.
  42. Enabling full representation in science: the San Francisco BUILD project's agents of change affirm science skills, belonging and community.
  43. Association Between Gestational Diabetes and Incident Maternal CKD: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
  44. APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.
  45. Bars, Nightclubs, and Cancer Prevention: New Approaches to Reduce Young Adult Cigarette Smoking.
  46. Origins of Cancer Disparities in Young Adults: Logic Models to Guide Research.
  47. Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.
  48. Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.
  49. Screening Pelvic Examinations-Reply.
  50. Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
  51. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
  52. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
  53. Update on Key Clinical Preventive Services for Adults.
  54. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
  55. 'Speaking Truth' Protects Underrepresented Minorities' Intellectual Performance and Safety in STEM.
  56. The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.
  57. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.
  58. Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife.
  59. Estimating the Prevalence of Sexual Minority Adolescents.
  60. Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.
  61. Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement.
  62. Developing Recommendations for Evidence-Based Clinical Preventive Services for Diverse Populations: Methods of the U.S. Preventive Services Task Force.
  63. Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement.
  64. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.
  65. Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.
  66. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.
  67. Breastfeeding associated with higher lung function in African American youths with asthma.
  68. Perceived Discrimination Associated With Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies.
  69. Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.
  70. The Effects of Migration and Assortative Mating on Admixture Linkage Disequilibrium.
  71. Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina.
  72. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
  73. Exercise Capacity, Heart Failure Risk, and Mortality in Older Adults: The Health ABC Study.
  74. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.
  75. Colorectal Cancer Screening Recommendations-Reply.
  76. Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement.
  77. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.
  78. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
  79. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
  80. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement.
  81. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services Task Force.
  82. Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals.
  83. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
  84. Early-life ozone exposure associated with asthma without sensitization in Latino children.
  85. Management of Hypertension in Primary Care Safety-Net Clinics in the United States: A Comparison of Community Health Centers and Private Physicians' Offices.
  86. Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement.
  87. Air Pollution and Lung Function in Minority Youth with Asthma in the GALA II (Genes-Environments and Admixture in Latino Americans) and SAGE II (Study of African Americans, Asthma, Genes, and Environments) Studies.
  88. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
  89. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.
  90. Novel genetic risk factors for asthma in African American children: Precision Medicine and the SAGE II Study.
  91. Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study.
  92. Controversies in Breast Cancer Screening Strategies.
  93. Dietary Salt, Kidney Disease, and Cardiovascular Health.
  94. Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study.
  95. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
  96. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.
  97. Racial Differences in Left Atrial Size: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
  98. Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.
  99. Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.
  100. Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study.
  101. Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement.
  102. Convergence and Divergence Around Breast Cancer Screening.
  103. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
  104. Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled.
  105. Evidence-Based Clinical Prevention in the Era of the Patient Protection and Affordable Care Act: The Role of the US Preventive Services Task Force.
  106. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.
  107. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement.
  108. Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes: U.S. Preventive Services Task Force Recommendation Statement.
  109. Screening for Thyroid Dysfunction.
  110. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement.
  111. Statins for Primary Prevention in Adults Aged 75 Years or Older.
  112. Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement.
  113. The US Preventive Services Task Force: What Is It and What Does It Do?
  114. Estimated GFR and Subsequent Higher Left Ventricular Mass in Young and Middle-Aged Adults With Normal Kidney Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
  115. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
  116. Screening for Speech and Language Delay and Disorders in Children Aged 5 Years or Younger: US Preventive Services Task Force Recommendation Statement.
  117. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
  118. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease.
  119. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma.
  120. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.
  121. Missed opportunities: young adults with hypertension and lifestyle counseling in clinical practice.
  122. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.
  123. Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.
  124. Cost-effectiveness of hypertension therapy according to 2014 guidelines.
  125. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement.
  126. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis.
  127. Behavioral counseling interventions to prevent sexually transmitted infections: U.S. PreventiveServices Task Force recommendation statement.
  128. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.
  129. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
  130. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.
  131. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement.
  132. Genetic ancestry influences asthma susceptibility and lung function among Latinos.
  133. Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.
  134. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.
  135. A Culturally Appropriate Educational Intervention Can Improve Self-Care in Hispanic Patients With Heart Failure: A Pilot Randomized Controlled Trial.
  136. Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement.
  137. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.
  138. Screening for suicide risk in adolescents, adults, and older adults in primary care: U.S. Preventive Services Task Force recommendation statement.
  139. Socioeconomic status and asthma control in African American youth in SAGE II.
  140. Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
  141. Prevention of dental caries in children from birth through age 5 years: US Preventive Services Task Force recommendation statement.
  142. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement.
  143. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
  144. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
  145. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
  146. Framingham score and LV mass predict events in young adults: CARDIA study.
  147. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement.
  148. Exhaustion of food budgets at month's end and hospital admissions for hypoglycemia.
  149. The institute of medicine report sodium intake in populations: assessment of evidence: summary of primary findings and implications for clinicians.
  150. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model.
  151. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.
  152. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.
  153. Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.
  154. Socioeconomic status and childhood asthma in urban minority youths. The GALA II and SAGE II studies.
  155. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
  156. Primary care interventions to prevent tobacco use in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
  157. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
  158. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement.
  159. Summaries for patients. Screening for glaucoma: U.S. Preventive Services Task Force recommendation statement.
  160. Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
  161. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina.
  162. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.
  163. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.
  164. Primary care interventions to prevent tobacco use in children and adolescents: U.S. preventive services task force recommendation statement.
  165. Primary care interventions to prevent child maltreatment: U.S. Preventive Services Task Force recommendation statement.
  166. Race, life course socioeconomic position, racial discrimination, depressive symptoms and self-rated health.
  167. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement.
  168. Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies.
  169. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.
  170. Housing instability and incident hypertension in the CARDIA cohort.
  171. Response to mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches.
  172. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement.
  173. Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
  174. Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement.
  175. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study.
  176. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches.
  177. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.
  178. Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study.
  179. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
  180. Screening for hearing loss in older adults: U.S. Preventive Services Task Force recommendation statement.
  181. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.
  182. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement.
  183. Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.
  184. Missed opportunities for treatment of uncontrolled hypertension at physician office visits in the United States, 2005 through 2009.
  185. A call to our hospitals: please hold the salt!: comment on "evaluation of sodium levels in hospital patient menus".
  186. Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement.
  187. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement.
  188. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement.
  189. Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study.
  190. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
  191. Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement.
  192. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
  193. Prevention of Falls in Community-Dwelling Older Adults: U.S. Preventive Services Task Force Recommendation Statement.
  194. Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study.
  195. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes.
  196. Blood pressure matters, even during young adulthood.
  197. Genetic association for renal traits among participants of African ancestry reveals new loci for renal function.
  198. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.
  199. Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study.
  200. Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults.
  201. The impact of the aging population on coronary heart disease in the United States.
  202. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.
  203. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study.
  204. Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics.
  205. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.
  206. Patient-physicians' information exchange in outpatient cardiac care: time for a heart to heart?
  207. Menstrual irregularity and cardiovascular mortality.
  208. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial.
  209. Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States.
  210. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites.
  211. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
  212. Caring for the "young invincibles".
  213. Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations.
  214. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.
  215. Projected effect of dietary salt reductions on future cardiovascular disease.
  216. The Association of African Ancestry and elevated creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
  217. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model.
  218. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
  219. Unraveling the relationship between literacy, language proficiency, and patient-physician communication.
  220. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study.
  221. Incarceration, incident hypertension, and access to health care: findings from the coronary artery risk development in young adults (CARDIA) study.
  222. Racial differences in incident heart failure among young adults.
  223. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.
  224. Coronary heart disease attributable to passive smoking: CHD Policy Model.
  225. Prehypertension during young adulthood and coronary calcium later in life.
  226. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
  227. Adolescent overweight and future adult coronary heart disease.
  228. BiDil for heart failure in black patients.
  229. Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the Heart and Soul Study.
  230. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
  231. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
  232. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
  233. Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.
  234. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.
  235. Renal insufficiency as an independent predictor of mortality among women with heart failure.
  236. Predictors of heart failure among women with coronary disease.
  237. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.
  238. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.
  239. Effects of primary care coordination on public hospital patients.
  240. Binding in vitro of phosphotyrosine-containing proteins to pp60c-src SH2 domain does not correlate with CEF transformation.
  241. Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527.
  242. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
  243. Human homologs of two testes-expressed loci on mouse chromosome 17 map to opposite arms of chromosome 6.